Clearance Summary
Comprehensive Segmental Revision System (SRS) received FDA 510(k) clearance under submission number K173411, sponsored by Biomet Manufacturing Corp. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2018-02-08.
- Submission: K173411
- Applicant / Sponsor: Biomet Manufacturing Corp
- Clearance pathway: Traditional
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.3660
- Decision date: 2018-02-08
Classification & Regulation
This clearance is catalogued under FDA product code PHX and 21 CFR 888.3660, within the Orthopedic review panel as a Class II device.